✦ LIBER ✦

Leishmania (Viannia) panamensis: An in vitro assay using the expression of GFP for screening of antileishmanial drug

✍ Scribed by Rubén E. Varela M; Diana Lorena Muñoz; Sara M. Robledo; Bala K. Kolli; Sujoy Dutta; Kwang Poo Chang; Carlos Muskus

Book ID: 113617765
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 409 KB
Volume: 122
Category: Article
ISSN: 0014-4894
DOI: 10.1016/j.exppara.2009.02.012

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Concordance analysis of an in vitro micr

Concordance analysis of an in vitro micronucleus screening assay and the regulatory chromosome aberration assay using pharmaceutical drug candidates

✍ Michael L. Homiski; Paula A. Muehlbauer; Krista L. Dobo; Maik J. Schuler; Jiri A 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 1 views

The Screening of River Water for Immunot

The Screening of River Water for Immunotoxicity Using an In Vitro Whole Blood Culture Assay

✍ Edmund J. Pool; Tandeka U. Magcwebeba 📂 Article 📅 2008 🏛 Springer Netherlands 🌐 English ⚖ 164 KB

Screening for phospholipidosis induced b

Screening for phospholipidosis induced by central nervous drugs: Comparing the predictivity of an in vitro assay to high throughput in silico assays

✍ Natalie Mesens; Margino Steemans; Erik Hansen; Geert R. Verheyen; Freddy Van Goe 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 350 KB

An in-vitro screening assay for the dete

An in-vitro screening assay for the detection of inhibitors of proinflammatory cytokine synthesis: a useful tool for the development of new antiarthritic and disease modifying drugs

✍ S. Laufer; C. Greim; T. Bertsche 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 310 KB

Establishment of an in vitro assay syste

Establishment of an in vitro assay system for screening hepatitis C virus protease inhibitors using high performance liquid chromatography: Kenji Sudo1,3, Hiroshi Inoue1, Yasuaki Shimizu2, Kayo Yamaji2, Kenji Konno1, Shiro Shigeta3, Takashi Kaneko4, Tomoyuki Yokota1, and Kunitada Shimotohno4, Rational Drug Design Laboratories1, Fukushima 960-12, Molecular Medicine Research Laboratories, Yamanouchi Pharmaceutical Co. Ltd.2, Tsukuba-shi, Ibaraki 305, Department of Microbiology, Fukushima Medical College3, Fukushima 960-12, Virology Division, National Cancer Center Research Institute4, Tokyo 104, Japan

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 113 KB